Gabelli & Co Investment Advisers’s Epizyme, Inc EPZM Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-482,200	Closed	-$709K	–	522
2022 Q2	$709K	Buy	+482,200	New	+$354K	0.09%	166

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Gabelli & Co Investment Advisers's EPZM Position: Q3 2022 in Review

Gabelli & Co Investment Advisers sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 482,200 shares — an estimated $709K sold.

Gabelli & Co Investment Advisers first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $709K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Gabelli & Co Investment Advisers reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 482,200 Epizyme, Inc shares in Q3 2022, an estimated $709K.
Gabelli & Co Investment Advisers first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Epizyme, Inc position peaked at $709K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.